253 related articles for article (PubMed ID: 30793414)
21. Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study.
Merante D; Rosenstock J; Sharma U; Feins K; Hsu C; Vinik A;
Pain Med; 2017 Nov; 18(11):2198-2207. PubMed ID: 28371941
[TBL] [Abstract][Full Text] [Related]
22. Efficacy Analysis of Capsaicin 8% Patch in Neuropathic Peripheral Pain Treatment.
Tenreiro Pinto J; Pereira FC; Loureiro MC; Gama R; Fernandes HL
Pharmacology; 2018; 101(5-6):290-297. PubMed ID: 29587275
[TBL] [Abstract][Full Text] [Related]
23. Use of High-Concentration Capsaicin Patch for the Treatment of Pelvic Pain: Observational Study of 60 Inpatients.
Levesque A; Riant T; Labat JJ; Ploteau S
Pain Physician; 2017; 20(1):E161-E167. PubMed ID: 28072808
[TBL] [Abstract][Full Text] [Related]
24. Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course.
Perez-Lloret S; Rojas GM; Menoni MC; Ruiz G; Velásquez C; Rodriguez H; Rey MV; Cardinali AD;
Clin Neuropharmacol; 2012; 35(1):21-4. PubMed ID: 22156921
[TBL] [Abstract][Full Text] [Related]
25. Does Duration of Neuropathic Pain Impact the Effectiveness of Pregabalin?
Pérez C; Latymer M; Almas M; Ortiz M; Clair A; Parsons B; Varvara R
Pain Pract; 2017 Apr; 17(4):470-479. PubMed ID: 27589095
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of peripheral neuropathic pain patients with repeated applications of high-concentration capsaicin cutaneous patch: Results of a retrospective chart review in Germany.
Kern KU; Quandel T; Theis S; Schubert T
Pain Pract; 2024 Jun; 24(5):700-708. PubMed ID: 38321913
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Impact of Capsaicin 8% Patch on Quality of Life in Patients with Lumbosacral Pain: An Open-label Study.
Zis P; Bernali N; Argira E; Siafaka I; Vadalouka A
Pain Physician; 2016; 19(7):E1049-53. PubMed ID: 27676676
[TBL] [Abstract][Full Text] [Related]
28. 8% Capsaicin Patch in Treatment of Peripheral Neuropathic Pain.
Goncalves D; Rebelo V; Barbosa P; Gomes A
Pain Physician; 2020 Sep; 23(5):E541-E548. PubMed ID: 32967405
[TBL] [Abstract][Full Text] [Related]
29. A preliminary prospective observational study of the effectiveness of high-concentration capsaicin cutaneous patch in the management of chronic post-surgical neuropathic pain.
Mullins CF; Walsh S; Rooney A; McCrory C; Das B
Ir J Med Sci; 2022 Apr; 191(2):859-864. PubMed ID: 33983564
[TBL] [Abstract][Full Text] [Related]
30. Treatment of painful radiculopathies with capsaicin 8% cutaneous patch.
Baron R; Treede RD; Birklein F; Cegla T; Freynhagen R; Heskamp ML; Kern KU; Maier C; Rolke R; Seddigh S; Sommer C; Ständer S; Maihöfner C
Curr Med Res Opin; 2017 Aug; 33(8):1401-1411. PubMed ID: 28436279
[TBL] [Abstract][Full Text] [Related]
31. A randomized, prospective study of efficacy and safety of oral tramadol in the management of post-herpetic neuralgia in patients from north India.
Saxena AK; Nasare N; Jain S; Dhakate G; Ahmed RS; Bhattacharya SN; Mediratta PK; Banerjee BD
Pain Pract; 2013 Apr; 13(4):264-75. PubMed ID: 22882673
[TBL] [Abstract][Full Text] [Related]
32. Qutenza patch--our early experience.
Weekes G; O'Brien J; Murphy K; Keavney J; Pollard V
Ir Med J; 2013 Mar; 106(3):89-90. PubMed ID: 23951983
[TBL] [Abstract][Full Text] [Related]
33. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study.
Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP
Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the effectiveness and safety of Ethosuximide in the Treatment of non-Diabetic Peripheral Neuropathic Pain: EDONOT-protocol of a randomised, parallel, controlled, double-blinded and multicentre clinical trial.
Kerckhove N; Mallet C; Pereira B; Chenaf C; Duale C; Dubray C; Eschalier A
BMJ Open; 2016 Dec; 6(12):e013530. PubMed ID: 27986742
[TBL] [Abstract][Full Text] [Related]
35. The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis.
Wagner T; Poole C; Roth-Daniek A
Pain Med; 2013 Aug; 14(8):1202-11. PubMed ID: 23710678
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy of OROS® hydromorphone combined with pregabalin for chronic non-cancer neuropathic pain.
Dauri M; Lazzari M; Casali M; Tufaro G; Sabato E; Sabato AF
Clin Drug Investig; 2014 May; 34(5):309-16. PubMed ID: 24567278
[TBL] [Abstract][Full Text] [Related]
37. NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
Irving G; Backonja M; Rauck R; Webster LR; Tobias JK; Vanhove GF
Clin J Pain; 2012 Feb; 28(2):101-7. PubMed ID: 21753727
[TBL] [Abstract][Full Text] [Related]
38. Neuropathic Pain Components in Patients with Cancer: Prevalence, Treatment, and Interference with Daily Activities.
Oosterling A; te Boveldt N; Verhagen C; van der Graaf WT; Van Ham M; Van der Drift M; Vissers K; Engels Y
Pain Pract; 2016 Apr; 16(4):413-21. PubMed ID: 25857631
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain.
Yoon DH; Bin SI; Chan SK; Chung CK; In Y; Kim H; Lichauco JJ; Mok CC; Moon YW; Ng TK; Penserga EG; Shin DA; You D; Moon H
BMC Musculoskelet Disord; 2017 Aug; 18(1):337. PubMed ID: 28778219
[TBL] [Abstract][Full Text] [Related]
40. Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic Pain.
Blair HA
Drugs; 2018 Sep; 78(14):1489-1500. PubMed ID: 30251173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
